Salt AI, the leader in contextual AI for enterprise applications in life sciences and health tech, announced a $10 million funding round, led by Morpheus Ventures, with participation from Struck Capital, Marbruck Investments and CoreWeave.

The company will use the capital to expand its customer footprint with leading biopharma and healthcare companies investing in the cutting edge of AI innovation, while also scaling their global AI engineering teams to accelerate delivery and impact. Customers are already deploying Salt Ai across drug discovery, clinical development, revenue cycle management, intelligent data navigation, and enterprise operations.